BMC Infectious Diseases · 2014 · 12 citations · 11 references
PharmacyInfectious DiseasesPharmacotherapyInflammationMolecular VirologyVirologyAntiretroviral TherapyAntiviral AgentsAntiviral PharmacologyAntiviral PharmacotherapyAntiviral TherapyHiv TestingAntiviral TherapeuticsCross-sectional Correlation StudyCross-sectional EpidemiologyHighly Active Antiretroviral TherapyImmune Reconstitution After Antiretroviral TherapyNested Pcr QuantificationTriple Combination TherapyViral Kinetics
BACKGROUND: Protease inhibitor monotherapy is associated with more frequent episodes of viral rebounds above 50 copies/mL than triple therapy. OBJECTIVE: To evaluate if, compared to triple-drug therapy, protease inhibitor monotherapy is associated with increased levels of inflammatory/procoagulant markers and more frequent plasma residual viremia detection. METHODS: In this cross-sectional study, we included patients treated for ≥ 1 year with darunavir/ritonavir or lopinavir/ritonavir as monotherapy (n=72) or with two nucleos(t)ides (n=74). All samples were tested for CRP, IL-6, fibrinogen and D-dimer. Residual viremia was determined using an ultrasensitive qualitative nested-PCR of the HIV pol gene with a limit of detection of 1 copy of HIV-RNA. RESULTS: We found no differences in levels of inflammatory/procoagulant markers or in the proportion of patients with plasma residual viremia detection by treatment group. CONCLUSION: The long-term treatment with protease inhibitor monotherapy in the setting of routine clinical practice is not associated with a higher prevalence of plasma residual viremia or more elevated inflammatory/procoagulant markers levels than triple drug therapy.
11
Sarah Palmer, Mary F. Kearney, Frank Maldarelli et al. · Journal of Clinical Microbiology · 2005 · 511 citations · Full text
Alison Rodger, Zoë Fox, Jens Lundgren et al. · The Journal of Infectious Diseases · 2009 · 170 citations · Full text
Tae‐Wook Chun, Danielle Murray, J. Shawn Justement et al. · The Journal of Infectious Diseases · 2011 · 162 citations · Full text
Robert C. Kalayjian, Rhoderick Machekano, Nesrine Rizk et al. · The Journal of Infectious Diseases · 2010 · 131 citations · Full text